Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

E-mail Alert Service

Contact Info

Therapeutic Effect of Anti-Fas Antibody on a Collagen Induced Arthritis Model

YUKIE OGAWA, HARUMI KUWAHARA, TOMOKO KIMURA, YOSHIO TANI, SHIN YONEHARA, AKIO SHIRAISHI, and MASAHIKO OHTSUKI

ABSTRACT.

Objective. To investigate the therapeutic effect of anti-Fas monoclonal antibody (Mab, RK-8) in collagen induced arthritis (CIA).

Methods. CD1F1 mice were immunized with bovine type II collagen to induce CIA and were treated with RK-8 intravenously. The effect of RK-8 was monitored by visual scoring. ELISA to detect serum anti-type II collagen antibody was performed on Day 47 and 70. Histopathological analysis was performed on Days 31 and 72. Digital micrography was performed on Day 72.

Results. RK-8 treatment almost completely prevented CIA. This suppressive effect continued after RK-8 was discontinued. RK-8 significantly suppressed the serum anti-type II collagen antibody level on Day 47. Histological analysis revealed that RK-8 significantly reduced joint histopathology, as determined by the infiltration of inflammatory cells and cartilage damage, consistent with digital micrography.

Conclusion. Administration of anti-Fas Mab may be a useful therapeutic strategy for rheumatoid arthritis if used early in the disease. (J Rheumatol 2001;28:950-5)

 

Key Indexing Terms:

ANIMAL MODELS
APOPTOSIS
ANTI-FAS ANTIBODY



Return to May 2001 Table of Contents



© 2001. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.